Phoenix Children’s: Comprehensive Care for GLUT1 Deficiency Syndrome

Phoenix Children’s Hospital in Arizona has been officially designated as a GLUT1 Deficiency Collaborative Care Network site. In partnership with the Barrow Neurological Institute, the facility now provides comprehensive, multidisciplinary care and specialized ketogenic diet therapy for children suffering from GLUT1 Deficiency Syndrome, a rare genetic disorder that impairs glucose transport to the brain.

For families navigating the labyrinth of rare neurological disorders, the primary obstacle is rarely a lack of will, but a lack of coordination. When a child’s brain is starved of its primary energy source—glucose—the resulting symptoms are not merely medical hurdles. they are daily crises. The struggle often involves a fragmented journey of “medical tourism,” where parents must act as the sole case managers, shuttling children between disconnected neurologists, dietitians, and geneticists.

This designation changes the geography of care in the Southwest.

The Glucose Gap: Understanding the Spectrum of GLUT1 DS

GLUT1 Deficiency Syndrome is more than a single diagnosis; it is a phenotypic continuum. At its core, the disorder prevents the brain from receiving sufficient glucose, the body’s main energy source. This energy deficit manifests in a variety of neurological symptoms, including epilepsy, developmental delays, and microcephaly—an abnormally small head size.

The complexity of the condition is found in its variety. Although some patients present with the classic phenotype, others experience a different set of challenges. Research from the National Center for Biotechnology Information highlights that the spectrum includes paroxysmal exercise-induced dyskinesia and epilepsy—formerly known as dystonia 18 (DYT18)—as well as paroxysmal choreoathetosis with spasticity, known as dystonia 9 (DYT9). Some children may too present with atypical childhood absence epilepsy or myoclonic seizures.

Given that the symptoms vary so wildly, a “one size fits all” approach to treatment is impossible. This is why the shift toward collaborative care is not just a preference, but a clinical necessity.

The Collaborative Care Center designation honors exceptional hospitals and clinics that demonstrate comprehensive, multidisciplinary, and patient-centered care and function collaboratively across the GLUT1 Deficiency community to further knowledge, advance research, and support patients and families.

A Multidisciplinary Fortress in Phoenix

The designation of Phoenix Children’s as a site within the GLUT1 Deficiency Foundation network means that the burden of coordination is shifted from the parent to the provider. The facility has assembled a specialized “strike team” designed to address every facet of the disorder simultaneously.

The clinical architecture of the program is led by Medical Director Randa Jarrar, MD, and Program Coordinator Lisa Vanatta, MS, RDN, CSP. However, the true strength of the site lies in its multidisciplinary depth. The team integrates:

• Clinical Nutrition: Christi Sports, MS, RDN, CSP, provides the essential oversight for ketogenic diet therapy.
• Neurological Support: Jalonna Ohr, PA-C, ensures pediatric neurology needs are met.
• Psychological Care: Tava Arnold, PhD, addresses the cognitive and emotional challenges associated with the syndrome.
• Pharmacological Expertise: Chris Kennie-Richardson, PharmD, manages the complex medication interactions.
• Care Coordination: Diana Laroque, RN, serves as the epilepsy nurse coordinator to bridge the gap between appointments.
• Genetic Analysis: Shagun Kaur, MD, provides critical insights via the Division of Genetics and Metabolism.

This level of integration is rare. Most families are forced to find these individual specialists across different healthcare systems. For those currently managing a diagnosis, securing vetted pediatric neurology specialists and clinical nutritionists who are familiar with the GLUT1 protocol is the most critical step in stabilizing a patient’s condition.

The Strategic Role of Ketogenic Therapy

Central to the mission at Phoenix Children’s is the implementation of ketogenic diet therapy. Because the brain cannot effectively transport glucose in GLUT1 DS patients, the ketogenic diet provides an alternative fuel source: ketones. This metabolic shift can significantly reduce seizure activity and improve cognitive function.

Implementing this diet is not as simple as changing a menu; it is a medical intervention that requires rigorous monitoring to avoid complications. The partnership with the Barrow Neurological Institute allows Phoenix Children’s to merge high-level neurological research with practical, bedside dietary application.

The logistical challenge of maintaining a strict ketogenic protocol often pushes families to seek facilitate beyond the clinic. Many are now consulting multidisciplinary medical centers that can offer long-term support and home-based monitoring to ensure the diet remains therapeutic without compromising the child’s growth.

This designation is a signal to the broader medical community in Arizona and beyond. It marks a transition from treating symptoms to managing a system.

As the medical community moves toward these “collaborative” models, the goal is to eliminate the “diagnostic odyssey”—the years of uncertainty and misdiagnosis that often precede a GLUT1 DS finding. The infrastructure now present at Phoenix Children’s serves as a blueprint for how rare genetic disorders should be handled: not as a series of isolated symptoms, but as a comprehensive life challenge requiring a unified front of experts. For those still searching for a path forward, the ability to find verified, multidisciplinary professionals is the only way to turn a rare diagnosis into a manageable life. The World Today News Directory remains the primary resource for connecting families with the specialized legal, medical, and nutritional professionals equipped to handle these complex cases.